Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-05-20
1990-08-21
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549401, A61K 3135, C07D31122
Patent
active
049506846
ABSTRACT:
This invention relates to novel compounds having a 2,2-di-substituted chromanonyl (benzopyran) ring structure which are antagonists of leukotriene D.sub.4 (LTD.sub.4) and the slow reacting substance of anaphylaxis (SRS-A). The compounds of this invention are useful as pharmaceutical agents to prevent or alleviate the symptoms associated with LTD.sub.4, such as allergic reactions and inflammatory conditions.
REFERENCES:
patent: 3882148 (1975-05-01), Augstein et al.
patent: 3952013 (1976-04-01), Hazard et al.
patent: 3953604 (1976-04-01), Warren
patent: 4006245 (1977-02-01), Augstein et al.
patent: 4133889 (1979-01-01), Augstein et al.
patent: 4156726 (1979-05-01), Brown et al.
patent: 4158663 (1979-06-01), Connor
patent: 4213903 (1980-07-01), Bantick et al.
patent: 4234726 (1980-11-01), Gardner
patent: 4238495 (1980-12-01), Warren et al.
patent: 4281008 (1981-07-01), Chamberlain et al.
patent: 4328230 (1982-05-01), Brown et al.
patent: 4546194 (1985-10-01), Miyano
patent: 4565882 (1986-01-01), Miyano
patent: 4665203 (1987-05-01), Miyano
patent: 4780469 (1988-10-01), Toda
Chemical Abstracts, CA 97:16807g, (1982).
Appleton et al., "Antagonists of Slow Reacting Substance of Anaphylaxis . . . ", J. Med. Chem., 20, 371-379, (1977).
Augstein et al., "Selective Inhibitor of Slow Reacting Substance of Anaphylaxis", Nature New Biology, 245, 215-217, (1973).
Deason James R.
Koszyk Francis J.
G. D. Searle & Co.
Kanady Mary Jo
Matukaitis Paul D.
Nucker Christine M.
Tsung Fredrick F.
LandOfFree
2,2-di-substituted benzopyran leukotriene-D.sub.4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,2-di-substituted benzopyran leukotriene-D.sub.4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,2-di-substituted benzopyran leukotriene-D.sub.4 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1678003